首页 › 基金 › Fairmount Funds Management LLC › IKT

Fairmount Funds Management LLC 对 IKT 的持仓历史

INHIBIKASE THERAPEUTICS INC · 医疗保健

Fairmount Funds Management LLC 在 Q3 2026 的 13F 申报中披露持有 IKT(INHIBIKASE THERAPEUTICS INC)8,625,000 股,市值约 US$17.7M,约占其申报组合的 1.11%,在其申报持仓中市值排名第 12 位。 Fairmount Funds Management LLC 最近 8 个申报季度中有 8 个季度披露了 IKT 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q3 2026)8.62M 股
申报持仓市值$17.72M
组合权重1.11%
首次申报Q4 2024
最近变动持有
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Fairmount Funds Management LLC 对 IKT 的持仓演变

Fairmount Funds Management LLC 于 Q4 2024 首次披露 IKT 持仓:6,125,000 股(约 US$19.9M)。 在 8 次申报中,Fairmount Funds Management LLC 1 次增持、0 次减持、6 次保持不变。 最近一期申报(Q3 2026)显示持股 8,625,000 股、市值约 US$17.7M。 持仓曾出现大幅变动:Q4 2025 增持约 41% (随后一个季度股价下跌 18%)。

逐季持仓明细

季度股数金额变化
Q4 2024 6.12M $19.91M 新进
Q1 2025 6.12M $13.41M 持有
Q2 2025 6.12M $11.94M 持有
Q3 2025 6.12M $9.92M 持有
Q4 2025 8.62M $17.68M 增持
Q1 2026 8.62M $14.49M 持有
Q2 2026 8.62M $17.51M 持有
Q3 2026 8.62M $17.72M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 IKT 与 13F 数据

IKT(INHIBIKASE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 62 只申报持有 IKT,申报仓位最大的包括:Sands Capital Alternatives, LLC (US$26.8M), Soleus Capital Management, L.P. (US$23.1M), Trails Edge Capital Partners, LP (US$18.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 IKT 的基金

查看 IKT 的全部基金持有人 →

常见问题

How long has Fairmount Funds Management LLC held IKT?

Fairmount Funds Management LLC has disclosed IKT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Fairmount Funds Management LLC's current position in IKT?

As of Q3 2026, Fairmount Funds Management LLC holds 8.62M shares of IKT (INHIBIKASE THERAPEUTICS INC), valued at $17.72M, representing 1.11% of its reported portfolio and ranking #12.

Has Fairmount Funds Management LLC been buying or selling IKT?

In the latest 13F filing (Q3 2026), Fairmount Funds Management LLC held unchanged its position in IKT.

Which other funds hold IKT?

Other major institutional holders of IKT include Sands Capital Alternatives, LLC, Soleus Capital Management, L.P., Trails Edge Capital Partners, LP, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.